Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update [PDF]
, 2018 et al,, Picus, Joel
core +1 more source
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers. [PDF]
BMC Pharmacol Toxicol, 2018 Costa MB +11 more
europepmc +1 more source
Evolution of cellular immune responses to hepatitis C virus during antiretroviral therapy and its clinical implications [PDF]
, 2010 Diepolder, Helmut M., Grüner, Norbert
core +1 more source
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. [PDF]
Am J Ophthalmol, 2019 Venkateswaran N +3 more
europepmc +1 more source
Pembrolizumab plus ipilimumab or pegylated interferon alfa-2b for patients with melanoma or renal cell carcinoma: take new drugs but keep the old? [PDF]
Ann Transl Med, 2019 Zibelman M, Plimack ER.
europepmc +1 more source
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma. [PDF]
J Clin Oncol, 2018 Davar D +18 more
europepmc +1 more source